Therapeutic Area | MeSH |
---|---|
infections | D007239 |
urogenital diseases | D000091642 |
immune system diseases | D007154 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE | Micro Laboratories | N-205626 DISCN | 2018-08-13 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VIRAMUNE | Boehringer Ingelheim | N-020933 RX | 1998-09-11 | 1 products, RLD, RS |
VIRAMUNE XR | Boehringer Ingelheim | N-201152 RX | 2011-03-25 | 2 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
acquired immunodeficiency syndrome | EFO_0000765 | D000163 | B20 |
hiv infections | EFO_0000764 | D015658 | B20 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Nevirapine, Viramune Xr, Boehringer Ingelheim | |||
8460704 | 2029-03-12 | U-1409 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 28 | 39 | 50 | 32 | 36 | 175 |
Hiv | D006678 | — | O98.7 | 3 | 6 | 4 | 13 | 11 | 33 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | 2 | 6 | 4 | 2 | 13 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 3 | 3 | 4 | 1 | 10 |
Malaria | D008288 | EFO_0001068 | B54 | 1 | — | 1 | 2 | 1 | 5 |
Hiv-1 | D015497 | — | — | 1 | 1 | 1 | 1 | — | 3 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | 1 | 2 |
Contraception | D003267 | — | — | — | 1 | — | 1 | — | 2 |
Hiv-associated lipodystrophy syndrome | D039682 | EFO_1001348 | — | — | — | — | 2 | — | 2 |
Hepatic insufficiency | D048550 | — | — | 1 | — | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | 2 | 6 | — | 1 | 10 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | 1 | 1 | — | 2 | 3 |
Coinfection | D060085 | — | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lipodystrophy | D008060 | HP_0009125 | E88.1 | — | 1 | — | — | 1 | 2 |
Parasitemia | D018512 | — | — | 1 | 1 | — | — | — | 1 |
Hiv seropositivity | D006679 | — | — | — | 1 | — | — | — | 1 |
Neutropenia | D009503 | — | D70 | — | 1 | — | — | — | 1 |
Anemia | D000740 | HP_0001903 | D64.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | — | 1 | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | — | — | — | 1 | 1 |
Wasting syndrome | D019282 | — | — | — | — | — | — | 1 | 1 |
Mycobacterium avium-intracellulare infection | D015270 | EFO_0007386 | — | — | — | — | — | 1 | 1 |
Neurobehavioral manifestations | D019954 | EFO_0004364 | — | — | — | — | — | 1 | 1 |
Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
Child behavior | D002652 | — | — | — | — | — | — | 1 | 1 |
Breast feeding | D001942 | — | — | — | — | — | — | 1 | 1 |
Cd4 lymphocyte count | D018791 | — | — | — | — | — | — | 1 | 1 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | — | — | — | 1 | 1 |
Drug common name | Nevirapine |
INN | nevirapine |
Description | Nevirapine is a dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection. It has a role as an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is a dipyridodiazepine and a member of cyclopropanes. |
Classification | Small molecule |
Drug class | tricyclic compounds; antivirals |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1 |
PDB | — |
CAS-ID | 129618-40-2 |
RxCUI | — |
ChEMBL ID | CHEMBL57 |
ChEBI ID | 63613 |
PubChem CID | 4463 |
DrugBank | DB00238 |
UNII ID | 99DK7FVK1H (ChemIDplus, GSRS) |